Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q1 2022 · 10-Q
Revenue$31.28M$31.28M+26.9% vs Q1 2021 Net Income$4.19M$4.19M−0.8% vs Q1 2021 EPS Diluted$0.01$0.01±0.0% vs Q1 2021 Gross Profit$16,976,000+28.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flow$8,490,000+25.6% Free Cash Flowderived$4,475,000+0.5% Margins · derivedGross margin54.3%+0.8 pt vs Q1 2021
Operating margin22.5%−6.0 pt vs Q1 2021
Net margin13.4%−3.7 pt vs Q1 2021
ended Mar 31, 2022 · filed May 10, 2022 · 40 d after period end